Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Comorbidity and Health Care Resource Use Among Commercially Insured Non-Elderly Patients With Diabetic Macular EdemaChristopher J Wallick, Ryan N Hansen, Joanna Campbell, et al.Ophthalmic Surgery, Lasers & Imaging Retina|July 19, 2014
Clinical monitoring of patients with age-related macular degeneration treated with intravitreal bevacizumab or ranibizumabSzilárd Kiss, Ying Liu, Joseph Brown, et al.Clinical Ophthalmology (Auckland, N.Z.)|September 12, 2014
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edemaSzilárd Kiss, Ying Liu, Joseph Brown, et al.Journal of the American Academy of Dermatology|February 20, 2007
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyNicholas J Lowe, Dee Anna Glaser, Nina Eadie, et al.American Journal of Ophthalmology|January 7, 2014
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degenerationNancy M Holekamp, Ying Liu, Wei-Shi Yeh, et al.Current Medical Research and Opinion|November 20, 2009
Resource use and costs of branch and central retinal vein occlusion in the elderlySharon Fekrat, Alisa M Shea, Bradley G Hammill, et al.Ophthalmology|December 22, 2009
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaSophie Rogers, Rachel L McIntosh, Ning Cheung, et al.Ophthalmology|February 25, 2012
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implantWei-Shi Yeh, Julia A Haller, Paolo Lanzetta, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2008
Resource use and costs associated with diabetic macular edema in elderly personsAlisa M Shea, Lesley H Curtis, Bradley G Hammill, et al.European Urology|April 3, 2012
OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trialClare J Fowler, Stephen Auerbach, David Ginsberg, et al.Pageof 3